HighVista Strategies’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,328	Closed	-$483K	–	171
2025 Q1	$483K	Buy	+13,328	New	+$483K	0.19%	128
2023 Q4	–	Sell	-14,591	Closed	-$520K	–	142
2023 Q3	$520K	Buy	14,591 +7,265	+99%	+$259K	0.24%	104
2023 Q2	$338K	Buy	+7,326	New	+$338K	0.15%	131